Lindus Health Named Fierce CRO Award Winner in the Outstanding Patient Recruitment and Retention Category
BOSTON, June 18, 2025 /PRNewswire/ -- Lindus Health, the anti-CRO running radically faster, more reliable clinical trials, has been honored the winner in the 2025 Fierce CRO Awards' Outstanding Patient Recruitment and Retention category, which celebrate exceptional achievements and innovations by Contract Research Organizations (CROs). These awards spotlight CROs that exemplify innovation, performance, and leadership in advancing life sciences research and improving patient outcomes.
Lindus Health earned this recognition for its innovative use of the Patient Identification Center (PIC) technique, which leverages advanced algorithms and customized search protocols based on real-world medical record data to reduce screen fail rates and accelerate recruitment with greater precision. This approach was instrumental in its collaboration with Myota on a pre-diabetes trial, which achieved a 54% screening conversion rate—five times the industry benchmark—and completed enrollment in just four months.
Backed by deep expertise in healthcare data, clinical systems, and physician behavior, Lindus Health's unique PIC approach stands out not just for using EHR-driven participant searches, but for how it executes them. While many CROs rely on medical practices to run standard queries, Lindus builds its own highly customized, in-house searches. These go beyond basic inclusion and exclusion criteria, incorporating a nuanced understanding of how data is actually recorded and coded by general practitioners. For example, when a trial sought patients with "reduced sexual desire," Lindus optimized results by using "low libido"—a term more commonly coded by GPs—significantly improving the ability to identify eligible participants.
"Receiving the Fierce CRO Award is a tremendous honor," said Meri Beckwith, co-founder of Lindus Health. "It reflects our mission to fix the broken clinical trial model so patients can access treatments faster. With innovative strategies like our PIC technique, smart study design, and proprietary AI, we're delivering faster, more precise, and cost-effective trials—even in complex cases. Our work isn't done though, and we're continuing to push the boundaries of what's possible in clinical research, making it more efficient, inclusive, and patient-centric every step of the way."
This award comes on the heels of Lindus Health's Series B funding round of $55 million, which is fueling strategic hiring across clinical operations and product development, while expanding the capabilities of its proprietary AI-powered eClinical platform, Citrus™. The investment is enabling advancements in study design optimization, automated central monitoring, and real-time biostatistics. As the only major service provider with a fully in-house platform, Lindus integrates all core clinical research technologies—including CTMS, EDC, eDiary, visit scheduling, and more—into a seamless, unified ecosystem.
In partnership with Oxford University, Lindus Health published a study on diverse perceptions of clinical trial participation, helping to inform more inclusive and patient-centered research. Additionally, Lindus is collaborating with CDISC, the organization that sets clinical data standards for the FDA, to develop standardized templates for clinical observations and is contributing to ARIA's Safeguarded AI program to improve trial design through safer, more reliable AI.
The full Fierce CRO Awards report profiling all winners is available here. Lindus Health's award-winning capabilities can be found at www.lindushealth.com.
About Lindus Health
Lindus Health is an anti-CRO running radically faster, more reliable clinical trials for life science pioneers – bringing ground-breaking treatments to patients more quickly. This is achieved through a commercial model that aligns incentives (fixed-priced quotes per study, with milestone-based payments), a world-class clinical operations team with its unique software platform, and access to over 40 million Electronic Health Records.
Clinical trials are the biggest bottleneck to advances in healthcare. Lindus Health removes this constraint through end-to-end execution of clinical studies driven by technology and forward-thinking approaches to clinical operations.
To date, Lindus Health has delivered clinical trials across the US, UK, and Europe to tackle a range of conditions, including diabetes, asthma, acne, social anxiety, major depressive disorder, hypertension, chronic fatigue syndrome and insomnia. The company has raised over $80M from investors including Peter Thiel, Balderton, Creandum, Firstminute Capital, and Seedcamp.
About Fierce BiotechFierce Biotech is the biotech industry's daily monitor, providing the latest news, articles, and resources related to clinical trials, drug discovery, FDA approval, FDA regulation, patent news, pharma news, biotech company news and more. More than 300,000 top biotech professionals rely on Fierce Biotech for an insider briefing on the day's top stories. Signup is free here.
Press contact:
Jodi PerkinsAmendola Communications for Lindus HealthJperkins@acmarketingpr.com Cell: 847.508.0877
View original content to download multimedia:https://www.prnewswire.com/news-releases/lindus-health-named-fierce-cro-award-winner-in-the-outstanding-patient-recruitment-and-retention-category-302485421.html
SOURCE Lindus Health
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
33 minutes ago
- Yahoo
Want to reduce your heart attack risk? Do this kind of exercise
When it comes to fortifying heart health and preventing a potential heart attack, cardiologists say one type of physical activity is better than the rest. Heart disease is the nation's top killer, with more than 371,000 Americans dying of coronary heart disease in 2022. 'Aerobic exercise training should be promoted above all else,' Dr. Luke Laffin, a preventive cardiologist and co-director of the Center for Blood Pressure Disorders at the Cleveland Clinic, told Aerobic exercises include walking or jogging, swimming or cycling – even dancing. These exercises raise your heart rate, with your cells using oxygen to produce energy, according to the Cleveland Clinic. They typically use large muscle groups in the body, too. Laffin says multiple studies have shown aerobic activity is better than other types of exercise when it comes to reducing the result of a heart attack. Here's what you should know... Aerobic activity – also known as cardio, referencing the Greek word for the heart – exercises the cardiovascular and respiratory systems, getting the heart to beat faster, according to Mayo Clinic. Over time, regular cardio can mean can mean your heart doesn't have to work as hard, Cleveland Clinic notes. Aerobic exercise can strengthen the blood vessels, improve the flow of oxygen throughout the body, lower blood pressure, increase 'good' cholesterol, and help to reduce the risk of heart disease – including coronary heart disease – and stroke. High blood pressure can lead to heart attack. Anaerobic exercise, including strength and high intensity interval training, can also strengthen the heart and lungs. But, the benefits are different. 'Aerobic exercise and resistance training are the most important for heart health,' Johns Hopkins exercise physiologist Kerry Stewart said. 'Although flexibility doesn't contribute directly to heart health, it's nevertheless important because it provides a good foundation for performing aerobic and strength exercises more effectively.' Well, federal health authorities say American adults need at least 150 minutes of moderate intensity physical activity each week. That's also what Laffin recommends, although the benefits grow if you do oven more. The Baylor College of Medicine says splitting the 150 minutes into 30-minute intervals allow for five active days and two rest days. 'Jog, swim, golf, hike, play basketball, dance, do yoga — whatever you love to do. The most important thing is to get out there and do it,' UT Southwestern Medical Center cardiologist Dr. Ben Levin advises.
Yahoo
35 minutes ago
- Yahoo
AM Best Revises Issuer Credit Rating Outlook to Positive for Florida Family Insurance Company and Its Subsidiary
OLDWICK, N.J., June 18, 2025--(BUSINESS WIRE)--AM Best has revised the outlook to positive from stable for the Long-Term Issuer Credit Rating (Long-Term ICR) and affirmed the Financial Strength Rating (FSR) of B++ (Good) and the Long-Term ICRs of "bbb" (Good) of Florida Family Insurance Company and its subsidiary, Florida Family Home Insurance Company, which together make up the two pool members of Florida Family Group (Florida Family). The outlook of the FSR is stable. Both companies are domiciled in Bonita Springs, FL. The Credit Ratings (ratings) reflect Florida Family's balance sheet strength, which AM Best assesses as strong, as well as its adequate operating performance, limited business profile and appropriate enterprise risk management (ERM). The revised outlook to positive from stable for the Long-Term ICR reflects improvements in Florida Family's balance sheet metrics, driven by a series of strategic initiatives undertaken by management. Primarily, beginning in 2022, the company launched a wind exposure reduction program in response to rising reinsurance costs, increased frequency of severe weather events, and an uncertain claims environment. The primary objectives of the program were to lower the probable maximum loss (PML), reduce reinsurance dependency, and enhance the overall risk profile of the book of business to deliver more consistent and dependable results. This effort led to a meaningful decline in wind-related exposures through 2025. Coupled with continued growth in policyholder surplus, lower PMLs and an adequate level of reinsurance coverage, these actions contributed to a notable improvement in Florida Family's risk-adjusted capitalization, which is assessed as strongest, as measured by Best's Capital Adequacy Ratio (BCAR). Florida Family continues to achieve organic surplus growth, further strengthening its balance sheet and supporting a positive trend across key financial metrics. Florida Family continues to achieve organic surplus growth, further strengthening its balance sheet and supporting a positive trend across key financial metrics. Additionally, the wind exposure reduction and other management initiatives are expected to enhance and stabilize operating performance through the enforcement of disciplined underwriting practices. AM Best anticipates that these efforts will help reduce volatility in reported operating results over time. The limited business profile reflects the limited geographic spread of risk in Florida. An appropriate ERM program is maintained through risk appetite and tolerance statements with risk management capabilities appropriately aligned with the concentrated risk profile. This press release relates to Credit Ratings that have been published on AM Best's website. For all rating information relating to the release and pertinent disclosures, including details of the office responsible for issuing each of the individual ratings referenced in this release, please see AM Best's Recent Rating Activity web page. For additional information regarding the use and limitations of Credit Rating opinions, please view Guide to Best's Credit Ratings. For information on the proper use of Best's Credit Ratings, Best's Performance Assessments, Best's Preliminary Credit Assessments and AM Best press releases, please view Guide to Proper Use of Best's Ratings & Assessments. AM Best is a global credit rating agency, news publisher and data analytics provider specializing in the insurance industry. Headquartered in the United States, the company does business in over 100 countries with regional offices in London, Amsterdam, Dubai, Hong Kong, Singapore and Mexico City. For more information, visit Copyright © 2025 by A.M. Best Rating Services, Inc. and/or its affiliates. ALL RIGHTS RESERVED. View source version on Contacts Josie Novak Senior Financial Analyst +1 908 882 2207 Christopher Draghi Director +1 908 882 1749 Christopher Sharkey Associate Director, Public Relations +1 908 882 2310 Al Slavin Senior Public Relations Specialist +1 908 882 2318 Error in retrieving data Sign in to access your portfolio Error in retrieving data
Forbes
35 minutes ago
- Forbes
Who Is The Billionaire Making A Bid For The Tampa Bay Rays?
By Thomas Gallagher Patrick Zalupski On Wednesday, the Tampa Bay Rays announced that a group led by Patrick Zalupski—a homebuilding billionaire–entered exclusive negotiations to buy the team from principal owner Stuart Sternberg. The price being discussed: $1.7 billion, according to Sportico. The announcement comes amid uncertainty regarding the team's future in the Tampa Bay area following a series of failed stadium proposals–including plans for renovations of Tropicana Field or a new ballpark in St. Petersburg. Now, ownership could be turned over to a group headed by the 44-year-old CEO of a publicly-traded developer. Zalupski, whose net worth Forbes estimates at $1.3 billion, is the founder and CEO of Dream Finders Homes, a Jacksonville-based company that describes itself as one of the country's fastest-growing homebuilders. Zalupski's group is in talks with Sternberg, a former partner at Goldman Sachs who purchased the Rays in 2004 with fellow Goldman Sachs partner Matthew Silverman for a reported $200 million. The two other buyers joining Zalupski, according to a Rays announcement, are Bill Cosgrove, CEO of Union Home Mortgage, and Ken Babby, the founder of the Fast Forward Sports Group and owner of two minor league baseball teams. Zalupski did not immediately reply to a request for comment from Forbes. Born in the suburbs of Detroit, Zalupski's family moved frequently during his childhood, as Forbes first reported in 2021. After graduating with a degree in finance from Stetson University, he became an auditor at FedEx, a job he felt dispassionate about. When his parents divorced, his mother moved to Jacksonville, Florida, where she worked as a realtor. Zalupski soon followed and began helping with her business. He flipped his first property in 2004 at age 24. Reinvesting the profits from the deal, he then bought a nine-unit condo project in 2006–just before the housing market crashed. Despite taking a loss on the investment, the mistake formed the foundation of Dream Finders, which Zalupski cofounded with a construction partner, Mark McGuigan, and McGuigan's wife, Tobi, in 2008. As the real estate market began to rebound following the financial crisis, Dream Finders built 27 homes the following year. By 2013, the company had sold a total of more than 1,000 homes, and Zalupski bought out the McGuigans for an undisclosed amount. Zalupski then expanded Dream Finders beyond Florida into Georgia, then Colorado and Texas. In 2021 he took the company public on the New York Stock Exchange. He owns about half the company's shares and has 84% of the voting rights. The business has been profitable every year since its founding, Zalupski told Forbes in 2021. That remains true four years later, based on Securities and Exchange Commission filings. In its most recent year, Dream Finders closed on 38,000 homes and earned $335 million in net income on revenue of $4.4 billion. More than 90% of Zalupski's estimated fortune lies in his Dream Finders shares, per Forbes calculations. Since taking the company public four years ago, he's sold about $20 million worth of his stock, plus has entered into more than one pre-paid forward only sale agreement. Just how he's going to come up with hundreds of millions of dollars to finance the purchase isn't clear, though there is always the chance he pulled out dividends when the company was private. He'll also have partners and the group will likely borrow to fund the deal. The Rays, meanwhile, have gone through a tough stretch. In 2024, the roof at the team's stadium, Tropicana Field, was destroyed by Hurricane Milton. For the 2025 season, the Rays elected to play home games at Steinbrenner Field, the Yankees' spring training stadium, located nearby in St. Petersburg. It only seats 11,026, making it the smallest ballpark in Major League Baseball and roughly a quarter the size of Tropicana. With ticket sales down for the 2025 season and the foreseeable future, Zalupski's group might have a plan to turn the franchise around. Despite being relegated to a stadium more compact than the Oakland A's, who are destined for relocation, billionaire Zalupski and his rich partners' potential ownership may be a needed shot in the arm for the team's stadium issues.
